Motif ID: Gcm2
Z-value: 2.394
Transcription factors associated with Gcm2:
Gene Symbol | Entrez ID | Gene Name |
---|---|---|
Gcm2 | ENSMUSG00000021362.6 | Gcm2 |
Top targets:
Gene overrepresentation in biological_process category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
48.4 | 145.1 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) activation of meiosis involved in egg activation(GO:0060466) |
6.7 | 20.2 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
4.8 | 38.4 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
4.3 | 8.6 | GO:0007632 | visual behavior(GO:0007632) |
4.0 | 12.1 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
3.8 | 3.8 | GO:1904173 | regulation of histone demethylase activity (H3-K4 specific)(GO:1904173) |
3.5 | 17.4 | GO:0015671 | oxygen transport(GO:0015671) |
3.2 | 9.5 | GO:2000852 | regulation of corticosterone secretion(GO:2000852) |
3.1 | 31.4 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
3.0 | 9.1 | GO:0021577 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
3.0 | 9.0 | GO:0030827 | negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
2.8 | 8.5 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
2.5 | 12.6 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
2.5 | 7.4 | GO:0046959 | habituation(GO:0046959) |
2.3 | 9.4 | GO:0035624 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
2.2 | 6.6 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
2.2 | 19.5 | GO:0071420 | cellular response to histamine(GO:0071420) |
2.2 | 6.5 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
2.1 | 6.4 | GO:1901731 | calcium-mediated signaling using extracellular calcium source(GO:0035585) positive regulation of platelet aggregation(GO:1901731) |
2.1 | 6.3 | GO:0010958 | regulation of amino acid import(GO:0010958) regulation of L-arginine import(GO:0010963) |
2.1 | 6.3 | GO:0071895 | odontoblast differentiation(GO:0071895) |
2.0 | 14.2 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
2.0 | 12.0 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
2.0 | 9.9 | GO:0051012 | microtubule sliding(GO:0051012) negative regulation of nonmotile primary cilium assembly(GO:1902856) |
2.0 | 7.9 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
2.0 | 9.9 | GO:0048069 | eye pigmentation(GO:0048069) |
1.9 | 5.8 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) |
1.9 | 5.8 | GO:0071544 | diphosphoinositol polyphosphate metabolic process(GO:0071543) diphosphoinositol polyphosphate catabolic process(GO:0071544) |
1.9 | 9.7 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
1.9 | 7.7 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
1.9 | 17.2 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
1.9 | 5.6 | GO:1904059 | positive regulation of sensory perception of pain(GO:1904058) regulation of locomotor rhythm(GO:1904059) |
1.9 | 7.4 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
1.8 | 7.3 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
1.8 | 9.0 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
1.8 | 7.2 | GO:1990035 | calcium ion import into cell(GO:1990035) |
1.8 | 7.1 | GO:0061526 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
1.7 | 5.1 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
1.6 | 6.6 | GO:0086045 | smooth muscle contraction involved in micturition(GO:0060083) membrane depolarization during AV node cell action potential(GO:0086045) membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
1.6 | 3.3 | GO:0070671 | response to interleukin-12(GO:0070671) |
1.6 | 3.2 | GO:0072053 | renal inner medulla development(GO:0072053) renal outer medulla development(GO:0072054) |
1.6 | 4.8 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylserine scrambling(GO:0061589) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
1.5 | 9.2 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
1.5 | 15.2 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
1.5 | 4.4 | GO:0009414 | response to water deprivation(GO:0009414) |
1.4 | 7.2 | GO:0031133 | regulation of axon diameter(GO:0031133) |
1.4 | 5.8 | GO:0021564 | glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
1.4 | 4.3 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
1.4 | 8.3 | GO:0046549 | retinal cone cell development(GO:0046549) |
1.3 | 8.1 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
1.3 | 6.7 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
1.3 | 9.1 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
1.3 | 1.3 | GO:0006622 | protein targeting to lysosome(GO:0006622) protein localization to lysosome(GO:0061462) |
1.3 | 13.9 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
1.3 | 2.5 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
1.2 | 6.2 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
1.2 | 6.2 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
1.2 | 3.7 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
1.2 | 3.7 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
1.2 | 3.5 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
1.2 | 18.6 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
1.2 | 10.4 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
1.1 | 2.3 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
1.1 | 3.3 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
1.1 | 10.7 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
1.1 | 8.5 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
1.0 | 5.2 | GO:0009074 | aromatic amino acid family catabolic process(GO:0009074) |
1.0 | 5.1 | GO:0070305 | response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
1.0 | 5.0 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
1.0 | 6.0 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
1.0 | 5.9 | GO:0032796 | uropod organization(GO:0032796) |
1.0 | 2.9 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
1.0 | 22.9 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.9 | 6.6 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.9 | 6.6 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.9 | 25.4 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.9 | 6.6 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.9 | 1.9 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.9 | 2.8 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.9 | 3.7 | GO:0006586 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.9 | 3.6 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.9 | 6.3 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.9 | 4.5 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.9 | 2.6 | GO:0035552 | oxidative single-stranded DNA demethylation(GO:0035552) |
0.9 | 0.9 | GO:0044830 | modulation by host of viral RNA genome replication(GO:0044830) |
0.9 | 3.5 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.9 | 2.6 | GO:0001193 | maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
0.9 | 2.6 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.9 | 2.6 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.9 | 13.6 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.8 | 0.8 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.8 | 5.0 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.8 | 14.0 | GO:0001553 | luteinization(GO:0001553) |
0.8 | 0.8 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.8 | 2.4 | GO:0035799 | ureter maturation(GO:0035799) |
0.8 | 4.9 | GO:0046541 | saliva secretion(GO:0046541) |
0.8 | 1.6 | GO:0042713 | negative regulation of urine volume(GO:0035811) sperm ejaculation(GO:0042713) |
0.8 | 3.2 | GO:0007135 | meiosis II(GO:0007135) meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.8 | 16.0 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.8 | 5.6 | GO:0030432 | peristalsis(GO:0030432) |
0.8 | 3.1 | GO:0046898 | response to cycloheximide(GO:0046898) |
0.8 | 2.3 | GO:0019085 | early viral transcription(GO:0019085) |
0.8 | 24.3 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.8 | 3.0 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.8 | 8.3 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.8 | 3.0 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.7 | 3.7 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.7 | 11.6 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.7 | 2.2 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.7 | 3.5 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.7 | 0.7 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.7 | 1.4 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.7 | 8.2 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.7 | 2.7 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.7 | 2.0 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
0.7 | 2.7 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.7 | 2.0 | GO:0051026 | chiasma assembly(GO:0051026) |
0.7 | 2.0 | GO:1900149 | positive regulation of Schwann cell migration(GO:1900149) |
0.7 | 2.0 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) |
0.7 | 3.9 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.6 | 9.6 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.6 | 3.2 | GO:0090292 | nuclear migration along microfilament(GO:0031022) nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.6 | 3.8 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
0.6 | 1.9 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.6 | 25.1 | GO:0034605 | cellular response to heat(GO:0034605) |
0.6 | 1.9 | GO:0070124 | mitochondrial translational initiation(GO:0070124) |
0.6 | 3.7 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.6 | 1.8 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
0.6 | 4.3 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.6 | 2.4 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.6 | 3.0 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.6 | 1.2 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.6 | 5.4 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.6 | 6.0 | GO:0015824 | proline transport(GO:0015824) |
0.6 | 2.4 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.6 | 2.4 | GO:0034727 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
0.6 | 5.3 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.6 | 4.1 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.6 | 2.9 | GO:0072015 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.6 | 2.9 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.6 | 2.8 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.6 | 3.4 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.6 | 2.2 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.6 | 1.7 | GO:1904049 | regulation of spontaneous neurotransmitter secretion(GO:1904048) negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
0.6 | 9.5 | GO:0017158 | regulation of calcium ion-dependent exocytosis(GO:0017158) |
0.6 | 6.1 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.6 | 2.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.5 | 3.3 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.5 | 1.1 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.5 | 0.5 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.5 | 11.9 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.5 | 5.4 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.5 | 25.1 | GO:0001881 | receptor recycling(GO:0001881) |
0.5 | 3.2 | GO:0032782 | bile acid secretion(GO:0032782) |
0.5 | 2.1 | GO:0071442 | regulation of histone H3-K14 acetylation(GO:0071440) positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.5 | 2.1 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.5 | 1.6 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) |
0.5 | 3.6 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.5 | 1.0 | GO:0003096 | renal sodium ion transport(GO:0003096) |
0.5 | 12.8 | GO:0060074 | synapse maturation(GO:0060074) |
0.5 | 6.6 | GO:0070445 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
0.5 | 1.0 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.5 | 3.0 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.5 | 5.4 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.5 | 2.9 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.5 | 2.9 | GO:0071732 | cellular response to nitric oxide(GO:0071732) |
0.5 | 6.3 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.5 | 2.4 | GO:0019695 | choline metabolic process(GO:0019695) |
0.5 | 0.5 | GO:1900424 | regulation of defense response to bacterium(GO:1900424) |
0.5 | 1.0 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.5 | 1.4 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.5 | 6.7 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.5 | 2.4 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.5 | 9.4 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.5 | 0.9 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.5 | 2.8 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.5 | 2.3 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
0.5 | 2.8 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.5 | 1.4 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.5 | 2.3 | GO:0070986 | left/right axis specification(GO:0070986) |
0.5 | 0.5 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.5 | 12.8 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.5 | 1.4 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.5 | 4.1 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.5 | 4.1 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.4 | 3.1 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.4 | 6.1 | GO:0006465 | signal peptide processing(GO:0006465) |
0.4 | 5.2 | GO:0071467 | cellular response to pH(GO:0071467) |
0.4 | 16.0 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.4 | 4.7 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.4 | 10.7 | GO:0009299 | mRNA transcription(GO:0009299) |
0.4 | 3.4 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.4 | 3.0 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.4 | 4.7 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.4 | 2.1 | GO:0042891 | antibiotic transport(GO:0042891) |
0.4 | 1.7 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
0.4 | 3.8 | GO:0050716 | positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
0.4 | 1.2 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
0.4 | 2.1 | GO:0030091 | protein repair(GO:0030091) |
0.4 | 1.2 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.4 | 2.8 | GO:2000348 | protein linear polyubiquitination(GO:0097039) regulation of CD40 signaling pathway(GO:2000348) |
0.4 | 0.4 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.4 | 4.4 | GO:0034389 | lipid particle organization(GO:0034389) |
0.4 | 14.3 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) |
0.4 | 2.8 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.4 | 2.0 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.4 | 1.6 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.4 | 4.7 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.4 | 2.7 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.4 | 4.2 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.4 | 1.1 | GO:0072338 | creatinine metabolic process(GO:0046449) cellular response to UV-A(GO:0071492) cellular lactam metabolic process(GO:0072338) |
0.4 | 1.8 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.4 | 4.0 | GO:1903861 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.4 | 3.2 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.4 | 5.0 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.4 | 2.1 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.4 | 7.1 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.3 | 2.1 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.3 | 1.4 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.3 | 0.7 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.3 | 1.4 | GO:0046689 | response to mercury ion(GO:0046689) |
0.3 | 2.7 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.3 | 2.7 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.3 | 2.4 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.3 | 4.7 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.3 | 3.7 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.3 | 5.6 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.3 | 6.2 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.3 | 1.3 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.3 | 2.9 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.3 | 1.6 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.3 | 1.0 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.3 | 9.5 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.3 | 1.3 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.3 | 4.7 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.3 | 4.9 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.3 | 1.8 | GO:0072610 | interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) positive regulation of interleukin-12 secretion(GO:2001184) |
0.3 | 1.8 | GO:0048875 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
0.3 | 8.5 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.3 | 2.4 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.3 | 2.1 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.3 | 0.9 | GO:0048162 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.3 | 5.1 | GO:0048240 | sperm capacitation(GO:0048240) |
0.3 | 2.1 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.3 | 0.9 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.3 | 1.2 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.3 | 1.4 | GO:0045924 | regulation of female receptivity(GO:0045924) positive regulation of female receptivity(GO:0045925) |
0.3 | 7.5 | GO:0010107 | potassium ion import(GO:0010107) |
0.3 | 4.6 | GO:0002021 | response to dietary excess(GO:0002021) |
0.3 | 2.6 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.3 | 25.2 | GO:1903214 | regulation of protein targeting to mitochondrion(GO:1903214) |
0.3 | 6.8 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.3 | 0.8 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
0.3 | 0.8 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.3 | 3.3 | GO:0070842 | aggresome assembly(GO:0070842) |
0.3 | 4.4 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.3 | 1.3 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.3 | 3.2 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.3 | 1.1 | GO:0031529 | ruffle organization(GO:0031529) |
0.3 | 4.4 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.3 | 3.1 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.3 | 1.0 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.3 | 0.8 | GO:0009838 | abscission(GO:0009838) |
0.3 | 1.0 | GO:0019835 | cytolysis(GO:0019835) |
0.3 | 1.0 | GO:0045176 | apical protein localization(GO:0045176) |
0.2 | 2.5 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.2 | 2.0 | GO:0071281 | cellular response to iron ion(GO:0071281) |
0.2 | 3.2 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.2 | 7.8 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.2 | 5.1 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.2 | 6.0 | GO:0002931 | response to ischemia(GO:0002931) |
0.2 | 2.4 | GO:0042711 | maternal behavior(GO:0042711) |
0.2 | 2.1 | GO:0051014 | actin filament severing(GO:0051014) |
0.2 | 2.8 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.2 | 6.6 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.2 | 1.2 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.2 | 1.9 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.2 | 2.1 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.2 | 5.3 | GO:0032400 | melanosome localization(GO:0032400) |
0.2 | 0.4 | GO:0071879 | regulation of adrenergic receptor signaling pathway(GO:0071877) positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.2 | 13.3 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.2 | 0.7 | GO:0009644 | response to light intensity(GO:0009642) response to high light intensity(GO:0009644) |
0.2 | 10.1 | GO:0000045 | autophagosome assembly(GO:0000045) |
0.2 | 0.4 | GO:0019086 | late viral transcription(GO:0019086) |
0.2 | 0.4 | GO:0002182 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
0.2 | 3.6 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.2 | 2.3 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.2 | 7.5 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.2 | 5.8 | GO:0098927 | vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.2 | 0.4 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.2 | 0.8 | GO:0015886 | heme transport(GO:0015886) |
0.2 | 3.1 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
0.2 | 9.3 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.2 | 1.2 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.2 | 4.0 | GO:0070301 | cellular response to hydrogen peroxide(GO:0070301) |
0.2 | 3.7 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.2 | 5.5 | GO:0048260 | positive regulation of receptor-mediated endocytosis(GO:0048260) |
0.2 | 2.7 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.2 | 6.4 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.2 | 14.0 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.2 | 5.2 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.2 | 0.8 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.2 | 5.6 | GO:0042551 | neuron maturation(GO:0042551) |
0.2 | 1.0 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
0.2 | 4.0 | GO:0006491 | N-glycan processing(GO:0006491) |
0.2 | 7.2 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.2 | 1.7 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.2 | 9.6 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.2 | 2.0 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.2 | 0.4 | GO:0010872 | regulation of cholesterol esterification(GO:0010872) |
0.2 | 9.2 | GO:0022900 | electron transport chain(GO:0022900) |
0.2 | 4.9 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.2 | 1.2 | GO:0090043 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.2 | 4.6 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.2 | 1.9 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.2 | 4.6 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.2 | 1.4 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.2 | 2.4 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.2 | 0.7 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.2 | 2.4 | GO:0046856 | phospholipid dephosphorylation(GO:0046839) phosphatidylinositol dephosphorylation(GO:0046856) |
0.2 | 0.8 | GO:0006477 | protein sulfation(GO:0006477) |
0.2 | 0.5 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.2 | 2.8 | GO:0061099 | positive regulation of protein tyrosine kinase activity(GO:0061098) negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.2 | 2.5 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.2 | 1.5 | GO:0032060 | bleb assembly(GO:0032060) |
0.2 | 3.3 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.2 | 10.0 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.2 | 1.1 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.2 | 2.1 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) histone H4-K16 acetylation(GO:0043984) |
0.2 | 1.9 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.2 | 1.3 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.2 | 3.0 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.2 | 2.4 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.2 | 1.6 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.2 | 4.0 | GO:0035065 | regulation of histone acetylation(GO:0035065) |
0.2 | 0.3 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.2 | 0.9 | GO:0010747 | positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
0.2 | 5.5 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
0.2 | 1.8 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.2 | 20.4 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.2 | 2.0 | GO:0042407 | cristae formation(GO:0042407) |
0.1 | 1.2 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.1 | 3.0 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.1 | 2.2 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.1 | 14.7 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.1 | 3.1 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.1 | 3.2 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.1 | 4.9 | GO:0045921 | positive regulation of exocytosis(GO:0045921) |
0.1 | 0.7 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.1 | 1.9 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.1 | 0.5 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
0.1 | 1.1 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.1 | 4.2 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.1 | 0.5 | GO:1904690 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.1 | 5.5 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.1 | 0.9 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.1 | 1.4 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.1 | 2.1 | GO:0098930 | axonal transport(GO:0098930) |
0.1 | 4.9 | GO:0032091 | negative regulation of protein binding(GO:0032091) |
0.1 | 3.1 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.1 | 1.9 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.1 | 8.2 | GO:0007612 | learning(GO:0007612) |
0.1 | 1.0 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.1 | 0.5 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.1 | 1.8 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
0.1 | 0.4 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 0.5 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.1 | 0.3 | GO:1902605 | heterotrimeric G-protein complex assembly(GO:1902605) |
0.1 | 0.6 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 5.0 | GO:0070527 | platelet aggregation(GO:0070527) |
0.1 | 0.8 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.1 | 0.9 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.1 | 3.6 | GO:0072384 | organelle transport along microtubule(GO:0072384) |
0.1 | 1.1 | GO:0080009 | mRNA methylation(GO:0080009) |
0.1 | 2.5 | GO:0030262 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.1 | 1.7 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.6 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 1.9 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.1 | 1.2 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.1 | 0.8 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) negative regulation of receptor-mediated endocytosis(GO:0048261) |
0.1 | 0.3 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.6 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 0.5 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 1.1 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.1 | 2.5 | GO:0016197 | endosomal transport(GO:0016197) |
0.1 | 0.8 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.1 | 0.2 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 0.5 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 3.0 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.1 | 1.4 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.1 | 2.0 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.1 | 0.6 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.1 | 3.6 | GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061178) |
0.1 | 4.8 | GO:0014065 | phosphatidylinositol 3-kinase signaling(GO:0014065) |
0.1 | 3.5 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.1 | 0.9 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.1 | 1.9 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.1 | 0.2 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.1 | 1.2 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.1 | 0.4 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.1 | 0.8 | GO:0031103 | axon regeneration(GO:0031103) |
0.1 | 1.2 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.1 | 2.2 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.1 | 1.1 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.1 | 0.3 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.1 | 1.6 | GO:1901381 | positive regulation of potassium ion transmembrane transport(GO:1901381) |
0.1 | 0.3 | GO:0050812 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.1 | 1.2 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.1 | 1.6 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.1 | 1.5 | GO:0015807 | L-amino acid transport(GO:0015807) |
0.1 | 0.4 | GO:0014898 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.1 | 0.2 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) |
0.1 | 0.3 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 1.4 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.1 | 2.1 | GO:0015914 | phospholipid transport(GO:0015914) |
0.1 | 0.2 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.1 | 0.1 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.1 | 1.2 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.1 | 0.5 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.0 | 1.1 | GO:0009408 | response to heat(GO:0009408) |
0.0 | 0.3 | GO:0045974 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.0 | 0.4 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.2 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.0 | 0.3 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 1.5 | GO:1901216 | positive regulation of neuron death(GO:1901216) |
0.0 | 0.2 | GO:0010991 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
0.0 | 1.5 | GO:0008037 | cell recognition(GO:0008037) |
0.0 | 0.3 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.0 | 1.5 | GO:0048675 | axon extension(GO:0048675) |
0.0 | 0.2 | GO:0051084 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
0.0 | 0.3 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.0 | 1.2 | GO:0006626 | protein targeting to mitochondrion(GO:0006626) |
0.0 | 0.5 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.0 | 0.6 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.0 | 0.3 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.0 | 0.2 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.0 | 1.3 | GO:0031929 | TOR signaling(GO:0031929) |
0.0 | 0.3 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.0 | 0.2 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.0 | 0.1 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.0 | 0.9 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.0 | 1.6 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.0 | 0.2 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.0 | 0.1 | GO:0060768 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.0 | 0.4 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.0 | 0.2 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.2 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.0 | 0.4 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.0 | 0.2 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.1 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.0 | 0.3 | GO:0050770 | regulation of axonogenesis(GO:0050770) |
0.0 | 0.1 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 0.0 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.0 | 0.2 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
Gene overrepresentation in cellular_component category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.9 | 126.4 | GO:0051233 | spindle midzone(GO:0051233) |
2.7 | 13.5 | GO:0030314 | junctional membrane complex(GO:0030314) |
2.3 | 35.2 | GO:0043196 | varicosity(GO:0043196) |
2.1 | 6.3 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
2.1 | 12.4 | GO:1990635 | proximal dendrite(GO:1990635) |
2.0 | 7.9 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
2.0 | 21.6 | GO:0043083 | synaptic cleft(GO:0043083) |
1.6 | 13.1 | GO:0097433 | dense body(GO:0097433) |
1.5 | 6.1 | GO:0044301 | climbing fiber(GO:0044301) parallel fiber(GO:1990032) |
1.4 | 5.6 | GO:0008537 | proteasome activator complex(GO:0008537) |
1.3 | 5.3 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
1.3 | 13.2 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
1.2 | 4.9 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
1.2 | 11.0 | GO:0044327 | dendritic spine head(GO:0044327) |
1.2 | 3.6 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
1.2 | 9.2 | GO:0033269 | internode region of axon(GO:0033269) |
1.1 | 6.8 | GO:0008091 | spectrin(GO:0008091) |
1.1 | 11.1 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
1.1 | 19.5 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
1.0 | 3.9 | GO:0044306 | neuron projection terminus(GO:0044306) |
1.0 | 46.1 | GO:0044295 | axonal growth cone(GO:0044295) |
0.9 | 7.4 | GO:0033391 | chromatoid body(GO:0033391) |
0.9 | 5.4 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.9 | 10.8 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.9 | 9.6 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.9 | 2.6 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.8 | 31.7 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.8 | 3.9 | GO:0070876 | SOSS complex(GO:0070876) |
0.7 | 5.2 | GO:0070695 | FHF complex(GO:0070695) |
0.7 | 8.5 | GO:0000124 | SAGA complex(GO:0000124) |
0.7 | 2.8 | GO:0071797 | LUBAC complex(GO:0071797) |
0.7 | 3.5 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.6 | 1.9 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.6 | 6.3 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.6 | 5.7 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.6 | 5.0 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.6 | 1.9 | GO:1903095 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
0.6 | 1.8 | GO:0097233 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
0.6 | 7.4 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.6 | 11.3 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.6 | 2.2 | GO:1903349 | omegasome membrane(GO:1903349) |
0.6 | 2.2 | GO:0031673 | H zone(GO:0031673) |
0.5 | 2.7 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.5 | 5.2 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.5 | 9.8 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.5 | 2.0 | GO:0002141 | stereocilia ankle link(GO:0002141) |
0.5 | 6.8 | GO:0031253 | cell projection membrane(GO:0031253) |
0.5 | 5.3 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.5 | 1.9 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.5 | 2.4 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.5 | 2.8 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.5 | 8.0 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.5 | 5.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.5 | 1.8 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.4 | 3.1 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.4 | 4.9 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.4 | 12.5 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.4 | 18.5 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.4 | 1.3 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.4 | 5.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.4 | 2.6 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.4 | 1.7 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.4 | 1.2 | GO:0005940 | septin ring(GO:0005940) |
0.4 | 30.7 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.4 | 12.6 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.4 | 3.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.4 | 4.4 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.4 | 9.5 | GO:0043194 | axon initial segment(GO:0043194) |
0.4 | 1.2 | GO:0035102 | PRC1 complex(GO:0035102) |
0.4 | 2.0 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.4 | 8.9 | GO:0005921 | gap junction(GO:0005921) |
0.4 | 4.7 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.4 | 1.8 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.4 | 1.4 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.4 | 3.2 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.3 | 21.2 | GO:0005776 | autophagosome(GO:0005776) |
0.3 | 2.7 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.3 | 3.0 | GO:0008278 | cohesin complex(GO:0008278) |
0.3 | 1.6 | GO:0033270 | paranode region of axon(GO:0033270) |
0.3 | 1.9 | GO:0071439 | clathrin complex(GO:0071439) |
0.3 | 6.5 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.3 | 4.0 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.3 | 5.5 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.3 | 27.1 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.3 | 5.2 | GO:0005652 | nuclear lamina(GO:0005652) |
0.3 | 4.5 | GO:0005614 | interstitial matrix(GO:0005614) |
0.3 | 1.5 | GO:0097361 | CIA complex(GO:0097361) |
0.3 | 6.1 | GO:0005771 | multivesicular body(GO:0005771) |
0.3 | 14.6 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.3 | 7.3 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.3 | 1.9 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.3 | 10.4 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.3 | 2.1 | GO:0031209 | SCAR complex(GO:0031209) |
0.3 | 0.8 | GO:0097227 | sperm annulus(GO:0097227) |
0.3 | 3.6 | GO:0031932 | TORC2 complex(GO:0031932) |
0.3 | 3.8 | GO:0032590 | dendrite membrane(GO:0032590) |
0.3 | 1.0 | GO:1990130 | Iml1 complex(GO:1990130) |
0.3 | 2.5 | GO:0031045 | dense core granule(GO:0031045) |
0.2 | 4.1 | GO:0000145 | exocyst(GO:0000145) |
0.2 | 1.7 | GO:0001520 | outer dense fiber(GO:0001520) |
0.2 | 1.4 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.2 | 1.2 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.2 | 1.6 | GO:0030891 | VCB complex(GO:0030891) |
0.2 | 1.4 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.2 | 2.1 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.2 | 0.5 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.2 | 2.4 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.2 | 0.7 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.2 | 2.0 | GO:0061617 | MICOS complex(GO:0061617) |
0.2 | 3.7 | GO:0008305 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
0.2 | 2.2 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 1.9 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.2 | 2.6 | GO:0034706 | voltage-gated sodium channel complex(GO:0001518) sodium channel complex(GO:0034706) |
0.2 | 7.4 | GO:0030315 | T-tubule(GO:0030315) |
0.2 | 2.5 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.2 | 2.1 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.2 | 1.9 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 0.8 | GO:0005745 | m-AAA complex(GO:0005745) |
0.2 | 5.0 | GO:0001891 | phagocytic cup(GO:0001891) |
0.2 | 5.6 | GO:0030904 | retromer complex(GO:0030904) |
0.2 | 10.2 | GO:0009986 | cell surface(GO:0009986) |
0.2 | 1.2 | GO:0036157 | outer dynein arm(GO:0036157) |
0.2 | 2.5 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.2 | 1.5 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 1.9 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.2 | 11.4 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.2 | 6.4 | GO:0035861 | site of double-strand break(GO:0035861) |
0.2 | 0.5 | GO:0043540 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex(GO:0043540) |
0.2 | 4.6 | GO:0016235 | aggresome(GO:0016235) |
0.2 | 3.8 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.2 | 7.5 | GO:0072562 | blood microparticle(GO:0072562) |
0.2 | 5.4 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 2.2 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.2 | 3.4 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.2 | 8.3 | GO:0005871 | kinesin complex(GO:0005871) |
0.2 | 17.4 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.2 | 41.9 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.2 | 4.2 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.2 | 1.8 | GO:0005685 | U1 snRNP(GO:0005685) |
0.2 | 0.6 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 1.1 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
0.2 | 5.0 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 1.0 | GO:0033503 | HULC complex(GO:0033503) |
0.1 | 19.6 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.1 | 1.5 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.1 | 6.5 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 1.4 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 2.6 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.1 | 4.6 | GO:0070160 | occluding junction(GO:0070160) |
0.1 | 3.0 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 1.8 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.1 | 12.5 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 1.2 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 2.2 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 0.8 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 1.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 2.4 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.1 | 5.8 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 14.3 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 1.2 | GO:0045180 | basal cortex(GO:0045180) |
0.1 | 4.7 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 0.3 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.1 | 5.1 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.1 | 2.3 | GO:0030018 | Z disc(GO:0030018) |
0.1 | 9.8 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 1.1 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.1 | 0.9 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.1 | 0.3 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 5.3 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 29.6 | GO:0005768 | endosome(GO:0005768) |
0.1 | 0.3 | GO:0001940 | male pronucleus(GO:0001940) |
0.1 | 2.2 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 2.8 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 2.9 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 3.0 | GO:0043679 | axon terminus(GO:0043679) |
0.1 | 2.3 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 2.4 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 1.2 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.1 | 0.8 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.1 | 2.6 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.1 | 0.5 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.1 | 0.6 | GO:0000243 | commitment complex(GO:0000243) |
0.1 | 0.3 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 0.9 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 3.1 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 1.4 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 20.7 | GO:0043025 | neuronal cell body(GO:0043025) |
0.1 | 0.5 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 2.7 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.1 | 0.2 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 11.2 | GO:0031410 | cytoplasmic vesicle(GO:0031410) |
0.0 | 0.4 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.0 | 0.8 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 1.9 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 2.0 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 2.9 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.0 | 45.2 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.0 | 2.4 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 4.1 | GO:0030141 | secretory granule(GO:0030141) |
0.0 | 0.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.0 | 1.9 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 2.7 | GO:0005773 | vacuole(GO:0005773) |
0.0 | 1.0 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.1 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.0 | 0.4 | GO:0034703 | cation channel complex(GO:0034703) |
0.0 | 8.4 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.0 | 0.6 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
Gene overrepresentation in molecular_function category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.0 | 28.1 | GO:0033691 | sialic acid binding(GO:0033691) |
6.7 | 20.2 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
6.3 | 151.5 | GO:0043274 | phospholipase binding(GO:0043274) |
5.3 | 16.0 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) epinephrine binding(GO:0051379) |
4.7 | 37.6 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
4.3 | 17.4 | GO:0004096 | catalase activity(GO:0004096) |
3.2 | 22.6 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
3.2 | 15.8 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
2.5 | 7.5 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
2.2 | 13.2 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
2.0 | 12.1 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
1.9 | 5.7 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
1.9 | 5.7 | GO:0032450 | oligo-1,6-glucosidase activity(GO:0004574) maltose alpha-glucosidase activity(GO:0032450) |
1.9 | 7.6 | GO:0004111 | creatine kinase activity(GO:0004111) |
1.9 | 5.7 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
1.8 | 7.4 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) ankyrin repeat binding(GO:0071532) |
1.8 | 5.4 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
1.7 | 6.9 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
1.7 | 5.0 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
1.6 | 8.2 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
1.6 | 4.9 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
1.6 | 4.8 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
1.6 | 6.3 | GO:0019962 | interferon receptor activity(GO:0004904) type I interferon receptor activity(GO:0004905) type I interferon binding(GO:0019962) |
1.5 | 7.6 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
1.5 | 7.5 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
1.5 | 16.3 | GO:0038191 | neuropilin binding(GO:0038191) |
1.4 | 6.8 | GO:0034235 | GPI anchor binding(GO:0034235) |
1.3 | 44.0 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
1.3 | 10.5 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
1.3 | 19.5 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
1.2 | 3.7 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
1.2 | 3.7 | GO:0004510 | tryptophan 5-monooxygenase activity(GO:0004510) |
1.2 | 3.6 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
1.2 | 10.8 | GO:0019534 | toxin transporter activity(GO:0019534) |
1.2 | 8.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
1.2 | 3.6 | GO:0097001 | ceramide binding(GO:0097001) |
1.1 | 5.7 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
1.1 | 6.6 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
1.1 | 3.2 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
1.1 | 4.3 | GO:0050544 | arachidonic acid binding(GO:0050544) |
1.1 | 4.2 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
1.0 | 6.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
1.0 | 9.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
1.0 | 5.1 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
1.0 | 5.1 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
1.0 | 3.9 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
1.0 | 8.7 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
1.0 | 7.7 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
1.0 | 7.7 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.9 | 8.5 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.9 | 3.7 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.9 | 5.6 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.9 | 4.4 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.9 | 6.2 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.9 | 5.2 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.9 | 3.4 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.9 | 2.6 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.8 | 8.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.8 | 5.0 | GO:0052630 | CTP:2,3-di-O-geranylgeranyl-sn-glycero-1-phosphate cytidyltransferase activity(GO:0043338) phospholactate guanylyltransferase activity(GO:0043814) ATP:coenzyme F420 adenylyltransferase activity(GO:0043910) UDP-N-acetylgalactosamine diphosphorylase activity(GO:0052630) |
0.8 | 5.0 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.8 | 3.3 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.8 | 3.2 | GO:1902379 | chemoattractant activity involved in axon guidance(GO:1902379) |
0.8 | 4.0 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.8 | 31.9 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.8 | 14.2 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.8 | 12.8 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.8 | 2.3 | GO:0042030 | ATPase inhibitor activity(GO:0042030) angiostatin binding(GO:0043532) |
0.7 | 10.5 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.7 | 4.4 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.7 | 6.5 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.7 | 15.9 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.7 | 7.2 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.7 | 4.3 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.7 | 2.8 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.7 | 9.8 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.7 | 2.8 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.7 | 4.1 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.7 | 2.6 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.6 | 1.9 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.6 | 1.9 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.6 | 8.0 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.6 | 1.8 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.6 | 12.8 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.6 | 11.5 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.6 | 5.9 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.6 | 2.8 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.6 | 12.8 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.5 | 15.2 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.5 | 3.1 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.5 | 2.1 | GO:0080084 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.5 | 9.8 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.5 | 2.1 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.5 | 4.6 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.5 | 2.5 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.5 | 0.5 | GO:0019841 | retinol binding(GO:0019841) |
0.5 | 4.0 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.5 | 1.5 | GO:0001565 | phorbol ester receptor activity(GO:0001565) non-kinase phorbol ester receptor activity(GO:0001566) |
0.5 | 5.3 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.5 | 18.3 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.5 | 3.3 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.5 | 2.4 | GO:0097016 | L27 domain binding(GO:0097016) |
0.5 | 1.9 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.5 | 1.9 | GO:0008227 | G-protein coupled amine receptor activity(GO:0008227) |
0.5 | 1.4 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.5 | 1.8 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.4 | 1.8 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
0.4 | 7.2 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.4 | 9.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.4 | 1.3 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.4 | 2.2 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.4 | 3.1 | GO:0016918 | retinal binding(GO:0016918) |
0.4 | 2.2 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.4 | 3.1 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.4 | 1.3 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.4 | 6.3 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.4 | 8.0 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.4 | 6.3 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.4 | 4.6 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.4 | 2.9 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.4 | 0.8 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.4 | 21.3 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.4 | 2.4 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.4 | 1.2 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.4 | 1.6 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.4 | 7.9 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.4 | 8.2 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.4 | 3.1 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.4 | 1.6 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
0.4 | 5.9 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.4 | 3.9 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.4 | 4.3 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.4 | 4.7 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.4 | 3.8 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.4 | 4.2 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.4 | 4.1 | GO:0034943 | acyl-CoA ligase activity(GO:0003996) 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) very long-chain fatty acid-CoA ligase activity(GO:0031957) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.4 | 1.9 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.4 | 2.6 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.4 | 2.9 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.4 | 6.9 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.4 | 4.7 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.4 | 1.4 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.4 | 3.6 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.4 | 1.4 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.4 | 1.8 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.4 | 4.9 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.3 | 4.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.3 | 1.4 | GO:0019172 | glyoxalase III activity(GO:0019172) |
0.3 | 1.0 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.3 | 1.0 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.3 | 7.7 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.3 | 3.7 | GO:0001846 | opsonin binding(GO:0001846) |
0.3 | 1.3 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
0.3 | 2.0 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.3 | 4.9 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.3 | 11.4 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.3 | 0.9 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.3 | 1.2 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.3 | 1.2 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.3 | 6.1 | GO:0031489 | myosin V binding(GO:0031489) |
0.3 | 2.4 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.3 | 0.9 | GO:0004560 | alpha-L-fucosidase activity(GO:0004560) |
0.3 | 10.3 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.3 | 1.2 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.3 | 3.3 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.3 | 2.1 | GO:0015091 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
0.3 | 6.6 | GO:0035380 | C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity(GO:0000252) mevaldate reductase activity(GO:0004495) gluconate dehydrogenase activity(GO:0008875) epoxide dehydrogenase activity(GO:0018451) 5-exo-hydroxycamphor dehydrogenase activity(GO:0018452) 2-hydroxytetrahydrofuran dehydrogenase activity(GO:0018453) acetoin dehydrogenase activity(GO:0019152) phenylcoumaran benzylic ether reductase activity(GO:0032442) D-xylose:NADP reductase activity(GO:0032866) L-arabinose:NADP reductase activity(GO:0032867) D-arabinitol dehydrogenase, D-ribulose forming (NADP+) activity(GO:0033709) (R)-(-)-1,2,3,4-tetrahydronaphthol dehydrogenase activity(GO:0034831) 3-hydroxymenthone dehydrogenase activity(GO:0034840) very long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0035380) dihydrotestosterone 17-beta-dehydrogenase activity(GO:0035410) (R)-2-hydroxyisocaproate dehydrogenase activity(GO:0043713) L-arabinose 1-dehydrogenase (NADP+) activity(GO:0044103) L-xylulose reductase (NAD+) activity(GO:0044105) 3-ketoglucose-reductase activity(GO:0048258) D-arabinitol dehydrogenase, D-xylulose forming (NADP+) activity(GO:0052677) |
0.3 | 0.9 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.3 | 0.9 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.3 | 6.4 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.3 | 5.2 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.3 | 18.3 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.3 | 10.1 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.3 | 2.6 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.3 | 0.9 | GO:0031687 | A2A adenosine receptor binding(GO:0031687) |
0.3 | 5.9 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.3 | 2.8 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.3 | 5.3 | GO:0017161 | phosphohistidine phosphatase activity(GO:0008969) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) NADP phosphatase activity(GO:0019178) 5-amino-6-(5-phosphoribitylamino)uracil phosphatase activity(GO:0043726) phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity(GO:0052825) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) inositol-1,3,4-trisphosphate 1-phosphatase activity(GO:0052829) inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity(GO:0052830) inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity(GO:0052831) phosphatidylinositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052867) IDP phosphatase activity(GO:1990003) |
0.3 | 5.5 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.3 | 0.8 | GO:0031208 | POZ domain binding(GO:0031208) |
0.3 | 1.1 | GO:0016531 | copper chaperone activity(GO:0016531) |
0.3 | 4.0 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.3 | 2.1 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.3 | 13.6 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.3 | 0.8 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
0.3 | 8.7 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.3 | 7.3 | GO:0030507 | spectrin binding(GO:0030507) |
0.3 | 9.8 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.3 | 2.8 | GO:0030957 | Tat protein binding(GO:0030957) |
0.2 | 2.5 | GO:0050733 | RS domain binding(GO:0050733) |
0.2 | 5.2 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.2 | 1.2 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.2 | 5.3 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.2 | 1.6 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.2 | 1.4 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.2 | 0.9 | GO:0016004 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
0.2 | 6.5 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.2 | 4.4 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.2 | 0.7 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.2 | 8.3 | GO:0008748 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
0.2 | 2.7 | GO:0001163 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.2 | 1.5 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.2 | 3.7 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.2 | 2.0 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.2 | 7.8 | GO:0030552 | cAMP binding(GO:0030552) |
0.2 | 0.8 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
0.2 | 1.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.2 | 13.6 | GO:0008186 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.2 | 1.0 | GO:0035242 | histone-arginine N-methyltransferase activity(GO:0008469) protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.2 | 5.7 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.2 | 0.4 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.2 | 3.2 | GO:0005521 | lamin binding(GO:0005521) |
0.2 | 0.7 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.2 | 2.6 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.2 | 0.8 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.2 | 1.7 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.2 | 4.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.2 | 1.7 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.2 | 1.5 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.2 | 9.3 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.2 | 0.2 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.2 | 5.2 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.2 | 3.4 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.2 | 1.7 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.2 | 0.3 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.2 | 3.8 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.1 | 1.0 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.1 | 12.9 | GO:0003774 | motor activity(GO:0003774) |
0.1 | 1.9 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.1 | 2.3 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 16.2 | GO:0005516 | calmodulin binding(GO:0005516) |
0.1 | 3.5 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 19.2 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 2.4 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 6.4 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 1.0 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 4.1 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.1 | 0.4 | GO:0008527 | taste receptor activity(GO:0008527) |
0.1 | 3.2 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 5.1 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.1 | 1.9 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 20.4 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.1 | 3.6 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.1 | 1.1 | GO:0015266 | protein channel activity(GO:0015266) |
0.1 | 34.0 | GO:0043774 | UDP-N-acetylmuramoylalanyl-D-glutamyl-2,6-diaminopimelate-D-alanyl-D-alanine ligase activity(GO:0008766) ribosomal S6-glutamic acid ligase activity(GO:0018169) coenzyme F420-0 gamma-glutamyl ligase activity(GO:0043773) coenzyme F420-2 alpha-glutamyl ligase activity(GO:0043774) protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) protein-glycine ligase activity, elongating(GO:0070737) tubulin-glycine ligase activity(GO:0070738) |
0.1 | 0.2 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.1 | 1.0 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 2.4 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 1.0 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 1.8 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 1.8 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 3.8 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 2.8 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 1.1 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 1.4 | GO:0019825 | oxygen binding(GO:0019825) |
0.1 | 0.6 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.1 | 1.1 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.7 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 1.9 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.1 | 2.5 | GO:0052771 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.1 | 0.8 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 2.2 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 16.7 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.1 | 0.2 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.1 | 1.5 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 0.4 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 1.5 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.4 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.1 | 0.3 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.5 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 1.7 | GO:0043236 | laminin binding(GO:0043236) |
0.1 | 10.8 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.1 | 0.6 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 3.1 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 0.7 | GO:0030546 | receptor activator activity(GO:0030546) |
0.1 | 0.2 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 0.5 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 5.0 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.1 | 0.9 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 4.0 | GO:0019210 | protein kinase inhibitor activity(GO:0004860) kinase inhibitor activity(GO:0019210) |
0.1 | 0.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 1.5 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 0.4 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.1 | 2.8 | GO:0008026 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.1 | 0.5 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.1 | 11.9 | GO:0005543 | phospholipid binding(GO:0005543) |
0.0 | 0.4 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 1.3 | GO:0072509 | divalent inorganic cation transmembrane transporter activity(GO:0072509) |
0.0 | 0.3 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 0.4 | GO:0035925 | translation repressor activity, nucleic acid binding(GO:0000900) mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.0 | 0.1 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.0 | 0.4 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.0 | 0.3 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.0 | 0.2 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.5 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.0 | 2.1 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.0 | 0.0 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.5 | GO:0043621 | protein self-association(GO:0043621) |
0.0 | 0.2 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 1.0 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.0 | 0.2 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.5 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.0 | 0.1 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.6 | GO:0003727 | single-stranded RNA binding(GO:0003727) |